Revolution Medicines revenue and financials
$199.87Change from previous close: −3.76%Absolute change: −$7.81
Fiscal year ending in December. Sources and method on the page Methodology and sources.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 2,355 | 2,558 | 2,062 | 812 | 738 | 567 | — | — |
| Current assets | 2,075 | 2,328 | 1,879 | 660 | 590 | 454 | — | — |
| Cash and equivalents | 384 | 543 | 696 | 161 | 108 | 104 | 16.9 | 69.6 |
| Short-term investments | 1,642 | 1,746 | 1,157 | 484 | 469 | — | — | — |
| Receivables | — | 0.0 | 1.3 | 4.7 | 5.9 | — | — | — |
| Net property, plant and equipment | 165 | 142 | 100 | 73.7 | 71.2 | — | — | — |
| Goodwill | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 | — | — |
| Other intangible assets | 55.8 | 56.7 | 57.7 | 58.8 | 59.9 | — | — | — |
| Current liabilities | 290 | 164 | 144 | 62.0 | 60.4 | 47.2 | — | — |
| Accounts payable | 64.6 | 54.4 | 61.8 | 21.3 | 14.1 | — | — | — |
| Long-term debt | 268 | — | — | — | — | — | — | — |
| Total debt | 159 | 136 | 87.9 | 64.2 | — | — | — | — |
| Total liabilities | 723 | 293 | 236 | 127 | 135 | 92.7 | — | — |
| Total equity (incl. minority) | 1,631 | 2,265 | 1,826 | 685 | 603 | — | — | — |
| Retained earnings | -2,869 | -1,738 | -1,138 | -701 | -453 | — | — | — |